Results for kreatiinifosfokinaasi translation from Finnish to Bulgarian

Computer translation

Trying to learn how to translate from the human translation examples.

Finnish

Bulgarian

Info

Finnish

kreatiinifosfokinaasi

Bulgarian

 

From: Machine Translation
Suggest a better translation
Quality:

Human contributions

From professional translators, enterprises, web pages and freely available translation repositories.

Add a translation

Finnish

Bulgarian

Info

Finnish

kohonnut kreatiinifosfokinaasi

Bulgarian

повишаване на СРК

Last Update: 2011-10-23
Usage Frequency: 1
Quality:

Warning: This alignment may be wrong.
Please delete it you feel so.

Finnish

kohonnut kreatiinifosfokinaasi (cpk), lihaskipu

Bulgarian

Повишена cpk, миалгия

Last Update: 2011-10-23
Usage Frequency: 2
Quality:

Warning: This alignment may be wrong.
Please delete it you feel so.

Finnish

- kreatiinifosfokinaasi (ck) ≤ 2, 5 x uln

Bulgarian

- Креатин фосфокиназа (cpk) ≤ 2, 5 uln

Last Update: 2012-04-10
Usage Frequency: 4
Quality:

Finnish

kohonnut veren kreatiinifosfokinaasi myalgia selkäkipu

Bulgarian

Повишена серумна креатин - фосфокиназа Миалгия Болка в гърба

Last Update: 2012-04-10
Usage Frequency: 2
Quality:

Finnish

kreatiinifosfokinaasi - arvojen suureneminen kokonaisbilirubiini - arvojen suureneminen

Bulgarian

# '

Last Update: 2011-10-23
Usage Frequency: 1
Quality:

Warning: This alignment may be wrong.
Please delete it you feel so.

Finnish

kreatiinifosfokinaasi kohonnut veren kreatiniini kohonnut veren urea maksan toimintakokeiden epänormaali tulos lämpöhalvaus

Bulgarian

Наранявания, отравяния и усложнения, възникнали в резултат на интервенции

Last Update: 2011-10-23
Usage Frequency: 1
Quality:

Warning: This alignment may be wrong.
Please delete it you feel so.

Finnish

melko harvinaiset: poikkeava elektrokardiogrammi, aspartaattiaminotransferaasin nousu, veren kreatiinifosfokinaasi mm: n nousu, lämmönnousu

Bulgarian

Нечести: патологична електрокардиограма, повишена аспартатаминотрансфераза, повишена mm фракция на креатинфосфокиназата в кръвта, повишена телесна температура

Last Update: 2012-04-10
Usage Frequency: 2
Quality:

Finnish

muita merkkejä voivat olla esim. kreatiinifosfokinaasi - arvojen suureneminen, myoglobinuria (rabdomyolyysi) ja akuutti munuaisten vajaatoiminta.

Bulgarian

Ако пациент развие признаци и симптоми, показателни за НМС, или

Last Update: 2011-10-23
Usage Frequency: 1
Quality:

Warning: This alignment may be wrong.
Please delete it you feel so.

Finnish

useimmiten leflunomidin käytön yhteydessä ilmoitetut yleiset (≥ 1/ 100, < 1/ 10) haittavaikutukset ovat: lievä verenpaineen nousu, leukopenia, parestesia, päänsärky, huimaus, ripuli, pahoinvointi, oksentelu, suun limakalvon vauriot (esim. aftainen stomatiitti, suun haavaumat), vatsakipu, lisääntynyt hiustenlähtö, ekseema, ihottuma (mukaan lukien makulopapulaarinen ihottuma), kutina, kuiva iho, jännetupen tulehdus, kohonnut kreatiinifosfokinaasi, ruokahaluttomuus, laihtuminen (tavallisesti vähäpätöinen), astenia, lievät allergiset reaktiot ja maksa- arvojen nousu (transaminaasit [erityisesti alat], harvemmin gamma- gt, alkaliinifosfataasi, bilirubiini).

Bulgarian

Най- често съобщаваните чести (≥1/ 100 to < 1/ 10) нежелани лекарствени реакции при лефлуномид са: леко повишаване на кръвното налягане, левкопения, парестезия, главоболие, замаяност, диария, гадене, повръщане, нарушения на устната лигавица (напр. афтозен стоматит, язви в устата), коремна болка, засилен косопад, екзема, обрив (включително макулопапулозен обрив), сърбеж, суха кожа, повишаване на cpk, анорексия, загуба на тегло (обикновено незначима), астения, леки алергични реакции и повишаване на чернодробните показатели (трансаминази (особено АЛАТ), по- рядко гама- gt, алкална фосфатаза, билирубин)).

Last Update: 2012-04-10
Usage Frequency: 4
Quality:

Warning: Contains invisible HTML formatting

Get a better translation with
7,793,207,702 human contributions

Users are now asking for help:



We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. Learn more. OK